Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Clinical trial NCT05432804 · RECRUITING
Trial details
- NCT number
- NCT05432804
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-20
- Primary completion
- 2027-06-30
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.